|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
Goldberg, the vice president of the Center for Medicine in the Public Interest, argues that California's plan to lower drug prices for middle income families by trading on the state's Medicaid formulary will only hurt its poorest citizens.
The use of drug therapy to treat mental illness—a large proportion of the state's drug budgetprovides a case in point regarding the dangers of limiting access to a variety of prescription drugs. Selective serotonin reuptake inhibitors (SSRIs) are used to treat depression and a variety of affect disorders. There are more than a dozen existing SSRIs.
|home spotlight commentary research events news about contact links archives|